This inventor holds 1 USPTO granted patent. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: Goro Hayashi: Innovator in Pharmaceutical Chemistry
Introduction
Goro Hayashi is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work has led to advancements in analgesic agents, showcasing his expertise and innovative spirit.
Latest Patents
One of Goro Hayashi's key patents is titled "Novel azabicyclo octane derivative and process for preparing same." This patent describes a compound characterized by a specific formula, where R¹ can be hydrogen, phenyl, or various alkyl and cycloalkyl groups. R² is defined as hydrogen or a short-chain alkyl, while R³ can be hydrogen, alkanoyl, benzoyl, or nicotinoyl. The patent outlines several methods for preparing this compound, which is recognized for its potential use as an analgesic agent. Goro Hayashi holds 1 patent in this area.
Career Highlights
Goro Hayashi is associated with Tanabe Seiyaku Company, Limited, where he has contributed to various research initiatives. His work has been instrumental in developing new pharmaceutical products that address pain management. His innovative approach and dedication to research have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Goro Hayashi has collaborated with notable colleagues, including Mikio Takeda and Hirozumi Inoue. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Goro Hayashi's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key inventor in the field. His work continues to influence the development of effective analgesic agents, demonstrating the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile